Publication
Title
Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis
Author
Abstract
Introduction Spurious hemolysis of samples is the leading cause of interference in coagulation testing and was described to interfere in fibrinolysis assays. The influence of hemolysis on the procarboxypeptidase U (proCPU) system is not known. Methods By means of spiking of hemolysate in pooled normal plasma, the effect of hemolysis on CPU, proCPU, and functional clot lysis assays was assessed. The influence of hemolysis on CPU generation during in vitro clot lysis was also evaluated. Cutoffs corresponding to maximal acceptable bias were determined. Results and discussion When active CPU was added to pooled plasma, a severe decrease in activity – up to 97.2% inhibition – was seen with increasing plasma concentrations of oxyhemoglobin (oxyHb) and the 10% cutoff value was found to be 0.3 g/L oxyHb. Using an activity‐based assay, proCPU levels appeared to decrease gradually with increased hemolysis (maximal reduction of 19.5%) with a 10% cutoff value of 4.2 g/L oxyHb. The relative clot lysis time (CLT) showed a maximal negative bias of 68.5%. The reduction in CLT paralleled a significant reduction of the first CPU activity peak during clot lysis. The cutoff value for the CLT was 0.4 g/L oxyHb. In presence of thrombomodulin (TM), CLT+TM was not affected up to 8.0 g/L oxyHb. Conclusion These data indicate a clear inhibition of the CPU system because of hemolysis resulting in an increase of lysis in functional fibrinolysis assays. We were able to quantify the inhibitory effect and to propose cutoff values for every parameter.
Language
English
Source (journal)
Journal of thrombosis and haemostasis. - Oxford
Publication
Oxford : 2019
ISSN
1538-7933
DOI
10.1111/JTH.14432
Volume/pages
17 :6 (2019) , p. 878-884
ISI
000472191600006
Pubmed ID
30887647
Full text (Publisher's DOI)
Full text (open access)
Full text (publisher's version - intranet only)
UAntwerpen
Faculty/Department
Research group
Project info
Carboxypeptidase U - a new drug target for the improvement of treatment in acute ischemic stroke.
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 22.05.2019
Last edited 24.11.2024
To cite this reference